C-418/01
ECLI:EU:C:2003:537
- Súd
- Súdny dvor Európskej únie
- IČS
- 62001CC0418
- Zdroj
- eur-lex.europa.eu ↗
OPINION OF MR TIZZANO — CASE C-418/01
OPINION OF ADVOCATE GENERAL TIZZANO delivered on 2 October 2003 1
1. By an order of 12 July 2001 the Land- Facts and procedure gericht (Regional Court) Frankfurt am Main (Germany) (the Landgericht) referred to the Court for a preliminary ruling three questions concerning the interpretation of Article 82 EC. 2In summary the German court is asking whether in the circumstances set out an undertaking commits an abuse of a dominant position where it does not Facts underlying the dispute in the main proceedings permit (for valuable consideration) its competitors to use a database over which it claims copyright.
2. The dispute in the main proceedings is between IMS Health GmbH & Co. KG (IMS) and NDC Health GmbH & Co. KG (NDC) which in August 2000 took over Pharma Intranet Information AG (PII).
1 — Original language: Italian. 2 — That article provides: 'Any abuse by one or more under- 3. Both parties to the proceedings are takings of a dominant position within the common market or in a substantial part of it shall be prohibited as engaged in the collection, processing and incompatible with the common market in so far as it may interpretation of data concerning regional affect trade between Member States. Such abuse may, in particular, consist in: sales of pharmaceutical products in Ger- (a) directly or indirectly imposing unfair purchase or selling prices or other unfair trading conditions; many. For present purposes, it is important (b) limiting production, markets or technical development to to point out that the studies produced by the prejudice of consumers; (c) applying dissimilar conditions to equivalent transactions those companies are structured on the basis with other trading parties, thereby placing them at a of a geographical criterion under which the competitive disadvantage; (d) making the conclusion of contracts subject to acceptance data on the sales of medicines are grouped by the other parties of supplementary obligations which, together in a series of areas into which by their nature or according to commercial usage, have no connection with the subject of such contracts.' Germany is subdivided. I - 5042
LMS HEALTH
4. It is apparent from the order for a working group known as the RPM reference that for the purpose of its market working group ('Regionaler Pharmazeu- reports IMS in the 1970s initially subdi- tischer Markt' — regional pharmaceutical vided Germany into 418 segments which market). This working group which is were predominantly determined by the convened twice a year comprises firms in political boundaries of the urban and the pharmaceutical industry which are provincial districts. Since that structure customers of IMS. They make suggestions was not sufficiently accurate for the drug for improving and optimising market seg- manufacturers concerned, the federal terri- mentation in light of their particular tory was subdivided in 1989 into 1000 requirements. According to IMS the work- segments to take account, inter alia, of ing group (whose proposals have been diverse market conditions and marketing considered only in exceptional cases) in structures. Following introduction of the regard to fewer than 10% of the segments is five-digit postcode system on 1 June 1993 essentially a marketing instrument for tying market segmentation was again reworked customers to its products. Conversely, and a structure based on 1845 segments according to NDC, the working group was developed. Since January 2000 IMS played an important role in determining has been delivering its market reports on individual segments. the basis of a subdivision of German territory into 1860 segments or a further subdivision derived from it into 2847 segments (hereinafter, respectively the 'I860 brick structure' and the '2847 brick structure'). 7. The 1860 and 2847 brick structures were not used by IMS only for market reports sold to the pharmaceutical compa- nies but were also distributed free of charge to pharmacy accounting centres and asso- ciations of health insurance schemes. Con- 5. Those structures came into existence in sequently, according to the matters men- response to various factors, such as the tioned by the referring court, those struc- political boundaries of the municipalities tures became a normal standard for the and postcode areas. Detailed demarcation compilation of regional evaluations of the of segment boundaries is determined by German pharmaceutical market. The phar- other factors such as for example whether maceutical industry has adjusted its market- an urban or rural district is involved, ing and electronic data retrieval systems in communications and geographical concen- line with them. tration of pharmacies and doctors' prac- tices.
8. PII, founded by a former director of IMS, initially drew up its reports on the 6. In order to involve the pharmaceutical basis of a segmentation of German territory industry in the determination of its own into 2201 areas. It emerged from contacts structures, IMS some years ago established with potential customers that data pro-
I - 5043
OPINION OF MR TIZZANO — CASE C-418/01
cessed in that form would be difficult to That order was confirmed on 12 July 2001 market because it did not follow the by a judgment of the referring court but, on structures with which the pharmaceutical the date of the order for reference herein, it undertakings had brought themselves into had not acquired the force of res judicata. line. Accordingly, PIIwent over to working with 1860 and 3000 brick structures which were very close to those used by IMS. 3
10. In those proceedings the national court viewed the IMS structures as data banks (or parts thereof) which are protected by the German copyright law. Without expressing a view on the involvement of the RPM working group in the development of such structures, they considered IMS none the less to be a joint owner of copyright and Previous judgments of the national courts entitled as such to prevent unauthorised use of the structures.
9. In order to prevent the use of those structures, regarded as infringing its copy- right, IMS brought proceedings before the The interim decision of the European Landgericht, seeking adoption of urgent Commission and the orders of the Pre- measures to restrain such use. In granting sidents of the Court of First Instance and of that application on 27 October 2000, the the Court of Justice German court issued an interim injunction restraining P I Ifrom using the 3000 brick structure and any other structure derived from the IMS 1860 brick structure. On 19 June 2001 the appeal by PII against that 11. As emphasised by the national court, injunction was dismissed by a judgment of during the course of those proceedings the the Oberlandesgericht (Higher Regional use of IMS's structures also formed the Court), Frankfurt am Main. Consequently, subject-matter of competition proceedings it now has the force of res judicata. before the European Commission. Following acquisition of P I Iby NDC, an analogous injunction by way of order was obtained in the same terms against NDC.
3—The I860 brick structure included only 30 bricks which 12. Faced with the imminent adoption by were different from the corresponding structure used by the Landgericht of the first interim injunc- IMS, whilst the 3000 brick structure was based on the IMS 2847 brick structure with a further subdivision of around tion, NDC requested IMS to grant to it for 150 bricks. valuable consideration a licence to use its I - 5044
IMS HEALTH
structure over 1860 areas. In response to dominant position on the market for Ger- the refusal by IMS to grant it such a licence man regional sales data services (the whole NDC lodged a complaint of abuse of a German territory and a substantial part of dominant position with the Commission, at the common market). 6 the same time requesting it to adopt urgent measures.
15. On that premiss, in order to assess whether the refusal by IMS to grant a 13. The Commission upheld NDC's licence in respect of its structure constituted request and on 3 July 2001 adopted on an an abuse of a dominant position, the interim basis in line with the decision in Commission considered that it had to Camera Care 4Decision 2002/165/EC 'on a 'examine whether the 1860-brick or com- proceeding under Article 82 of the EC patible structure [was] indispensable to Treaty'. 5 By that decision the Commission compete on the relevant market, that is to (i) required IMS 'to grant a licence without say whether there [was] a realistic possibi- delay to all undertakings currently present lity for undertakings wishing to offer on the market for German regional sales regional sales data services in Germany to data services, on request and on a non- employ — instead of the 1860-brick or a discriminatory basis, for the use of the compatible structure — another structure 1860-brick structure, in order to permit the which would not infringe IMS's copy- use of and sales by such undertakings of right'. 7 Moreover, 'the answer to this regional sales data formatted according to question depend[ed] on whether there this structure' (Art. 1); (ii) provided for the [was] a real possibility for customers of manner in which royalties were to be regional sales data of buying data for- determined (Art. 2) and (iii) laid down the matted in another structure.' penalty for non-compliance to be imposed on IMS (Art. 30).
16. On the basis of its investigations and in particular in light of information received 14. In the part of the decision concerning from a number of pharmaceutical compa- the /limits boni juris and thus the prima nies questioned by it the Commission facie infringement of Article 82 EC by IMS reached an affirmative determination on the Commission considered that IMS held a thatquestion.'8
4 — Order of the Court i n Case 792/79 R Camera Care v 6 — Paragraphs 45 to 62. Commission |1980] ECR 119. 7 — Paragraph 71. 5 — OJ 2002 L 59, p. 18. 8 — Paragraph "2.
I - 5045
OPINION OF MR TIZZANO— CASE C-418/01
17. In that connection it highlighted a structure, whilst theoretically possible, series of factors tying customers (the would be an unviable economic propo- pharmaceutical companies) to IMS's 1860 sition'. 10 brick structure, in particular the matters set out below:
— 'Data for different time periods there- fore need to be comparable, and data in any new structure would have to be — the 'working group played an exten- converted to the 1860 structure (or sive role in designing' the 1860 brick vice versa) to ensure such comparabil- structure. 'The pharmaceutical indus- ity, at considerable cost.' 11 try in Germany invested considerable resources in ensuring that the brick structure fully met their requirements'. This in part explains their 'dependence, built up over a long period, on this structure, the extremely high disincen- tives they have to switch to a new one, and so the impossibility for a regional sales data service formatted in another — 'If regional sales data were supplied in structure to be able to compete'. 9 a structure which was not compatible with the 1860 structure, this would necessitate significant changes in the territories allocated to sales represen- tatives by their pharmaceutical compa- nies' with consequential 'loss of relationships between doctors and sales representatives' which would be the 'inevitable result of a change to a brick structure which was incompati- ble with the 1860-brick structure and — 'the 1860-brick structure functions as would act as a important disincentive an industry standard', in part because for certain pharmaceutical companies of the role played by the firms in this to make such a change.' 12 industry in its creation. The 'pharma- ceutical companies have become "locked in'" to 'this standard such that to switch away from it to buy sales 10 — Paragraphs 86 and 92. data formatted in a non-compatible 11 — Paragraph 93. 12 — Paragraph 114. With reference to the relationship between doctors and sales representatives the Commission observed in particular that 'the pharmaceutical companies attach great importance to the relationship between a doctor and a sales representative, which is one of the few means to 9 — Ibid. promote a drug.' (paragraph 113).
I - 5046
LMS HEALTH
— The sales territory, defined as the covered by sales representatives in a day, aggregation of a number of bricks, and so on), as noted above. The choice of may be 'indicated in the working boundaries between bricks depends greatly contract between the company and on these objective parameters, and so limits the sales representative, in which case the choices available to would-be structure a change of structure would require a creators'. 16 modification of the working contract. This procedure would be another disincentive to switch brick struc- ture'. 13
19. The Commission also pointed to other factors rendering unlikely the development of an alternative structure on the part of competitors of IMS, stressing in particular — The costs of modifying internal appli- legal uncertainty around selling data in a cations which are at present wholly new structure, 17unsuccessful past attempts dependent on the 1860-brick structure to create new structures 18and the impos- are significant and represent a signifi- sibility of obtaining pointers as to the cant disincentive to switching brick development of new structures from the structures.' 14 experience of other countries. 19
18. The Commission went on to highlight 20. On the basis of all the abovementioned the 'technical and legal constraints' which matters the Commission therefore consid- [might] make it unreasonably difficult for ered that the 1860-brick or compatible other undertakings to create another struc- structure was indispensable to compete on ture in which regional data sales services the relevant market. Taking the view that could be formatted and marketed in Ger- there were no objective grounds for refusal many'. 15 In that connection it observed that 'most of the parameters used in building the structure are in the public 16 — Paragraph 131. The Commission went on to state more domain and fixed (postcode areas, location specifically that 'the clear importance of using postcode areas limits the choices available to potential designers of of pharmacies and doctors, sociodemo- new brick structures' (paragraph 132); that 'there are graphic data, topology, territory able to be strong arguments for the necessity for brick structures to respect the boundaries of the 440 German Kreise' (paragraph 137), and that 'there is a probability that German data protection laws do impose certain constraints on the construction of a second structure in Germany' (paragraph 142). 13 — Paragraph 115. 17 — Paragraphs 143 to 145. 14 — Paragraph 122. 18 — Paragraphs 146 to 152. 15 — Paragraph 124. 19 — Paragraphs 153 to 166.
I - 5047
OPINION OF MR TIZZANO — CASE C-418/01
of a licence 20 the Commission accordingly in question for the technical, legal and held that such refusal constituted a prima economic constraints referred to above is facie abuse of a dominant position. incapable of being replicated by means of a non-infringing parallel creation'. 23 Again with reference to the Community case-law 'there [was] no requirement for a refusal to supply to prevent the emergence of a new product in order to be abusive'. 24
21. Replying to the arguments put forward by IMS that, in accordance with the relevant Community case-law, 'IMS is entitled to refuse licences of its copyright to competitors for the market to which copyright relates', 21 the Commission emphasised that 'the fact that the cases 22. By applications lodged on 6 August considered by the European Court of 2001 IMS applied to the Court of First Justice and Court of First Instance to which Instance for annulment under Article 230 IMS refers involved two markets does not EC of the Commission Decision and for preclude the possibility that a refusal to suspension of operation under Article 243 license an intellectual property right can be EC. By order of 26 October 2001 the contrary to Article 82.' 22 In order to President of the Court of First Instance establish an infringement of that provision granted 25 the application for interim suspen- in the present case, the Commission speci- sion. For present purposes it should be fically deemed the following matters to be emphasised that in the part of the order sufficient: (i) 'use of the 1860-brick struc- concerning whether there was a prima facie ture is an indispensable input to allow case the Court considered well founded (or undertakings to compete in the market for at least not manifestly unfounded) the regional sales data services in Germany'; (ii) arguments by IMS according to which the there is 'an important distinction between Commission had departed from Commu- the product, which is regional sales data nity case-law in holding that the refusal to services, and the brick structure in which grant a licence entailed an infringement of data used to create these services is for- Article 82 EC even where it did not prevent matted'; (iii) in 'the specific and exceptional 'the appearance of a new product on a circumstances in which the 1860-brick market separate from that on which26 the structure was developed and copyright undertaking in question is dominant.' was asserted and found to subsist, the work
23 — Paragraph 184. 24 — Paragraph 180. 20 — Paragraphs 167 to 174. 25 — Case T-184/01 R IMS Health v Commission [2001] ECR 21 — Paragraph 182. II-3193. 22 — Paragraph 184. 26 — Paragraph 105.
I - 5048
IMS HEALTH
23. The appeal by NDC against that order grant a licence constitutes an abuse of a was dismissed by the President of the Court dominant position, the Landgericht seeks a by order of 11 April 2002. 27 ruling by the Court on the following questions:
'1. Is Article 82 EC to be interpreted as meaning that there is abusive conduct by an undertaking with a dominant Main proceedings and questions referred position on the market where it refuses to grant a licence agreement for the use of a data bank protected by copyright to an undertaking which seeks access to the same geographical and actual market if the participants on the other 24. As stated in the order for reference, side of the market, that is to say IMS is pursuing its claim in the main potential clients, reject any product proceedings that NDC be denied use of which does not make use of the data the 1860-brick structure or any derivative bank protected by copyright because thereof. However, the Landgericht consid- their set-up relies on products manu- ers that the right to injunctive relief which is factured on the basis of that data in principle guaranteed in favour of IMS by bank? national copyright law cannot apply in the present case if the refusal by IMS to enter into a licence agreement with NDC on reasonable terms were to be held to constitute abusive conduct within the 2. Is the extent to which an undertaking meaning of Article 82 EC. with a dominant position on the market has involved persons from the other side of the market in the develop- ment of the data bank protected by copyright relevant to the question of abusive conduct by that undertaking?
25. On that point the referring court adopts the conclusions arrived at by the Commission in regard to the definition of relevant market and the dominant position 3. Is the material outlay (in particular in occupied by IMS. 28 However, in order to regard to costs) in which clients who establish whether the refusal by IMS to have hitherto been supplied with the product of the undertaking having a dominant market position would be 27 — C a s e C-418/01 P(R) NDC Health v IMS Health and involved if they were in future to go Commission [2002] LCR I-3401. over to purchasing the product of a 28 — The Landgericht refers specifically to paragraphs 45 to 55, 59 and 60 of the Commission Decision. competing undertaking which does not
I - 5049
OPINION OF MR TIZZANO — CASE C-418/01
make use of the data bank protected by which have already involved in various copyright relevant to the question of regards the Commission and the Presidents abusive conduct by an undertaking of the Court of First Instance and of the with a dominant position on the Court of Justice. Thus, in order to seek to market?' give a useful reply to the national court, in the light also of the Commission Decision and the interim orders adopted by the Community Courts, I consider it appro- priate to make some preliminary remarks concerning the scope of the questions and Procedure before the Court and the pro- the problems essentially raised by them. ceedings pending before the Court of First Instance
26. In the proceedings thus brought before the Court observations were submitted by the parties to the main proceedings and by the Commission. Those parties also pre- sented oral argument at the hearing on 6 March 2003. 29. I would begin by observing that the first question appears to be based on two hypotheses: (a) the use of a specific brick structure protected by copyright is essential to the marketing of studies on regional sales 27. In the case brought by IMS before the of medicines in a given country and thus to Court of First Instance for annulment of the the ability to operate on the relevant Commission Decision proceedings were market, inasmuch as the potential clients suspended by order dated 26 September (the pharmaceutical companies) refuse to 2002 pending delivery of judgment by the accept any study not carried out on the basis Court in the present case. of that structure; 29 (b) the undertaking owning the copyright of the structure in question holds a dominant position on the market for data services relating to regional sales of medicines in the country concerned. On the basis of those premisses, the national court seeks to ascertain whether Legal analysis Article 82 EC must be interpreted as meaning that, in such a situation, the undertaking owning the copyright is abus- ing its dominant position by refusing to Preliminary grant (for valuable consideration) a licence
29 — The ground for such refusal which does not seem to be 28. As has been seen, the questions referred challenged by the question under examination seems to be attributable to organisational problems on the part of form part of a complex series of matters pharmaceutical undertakings.
I - 5050
IMS HEALTH
for the use of its structure to persons erroneously adjudged that the refusal to seeking to use it in order to operate on the grant a licence constituted an infringement same market (geographical and product- of Article 82 EC even if it did not prevent based) in which the owner occupies the 'the emergence of a new product in a dominant position and asserts its right to market not connected with that in which that structure. the undertaking concerned was domi- nant'. 31
30. In other words, by its first question the national court is essentially seeking to 32. The two subsequent questions read in ascertain whether, in a situation of the type the light of the Commission Decision and described above, the refusal to grant a the interim orders seem instead to concen- licence may constitute an abuse of a trate on one of the matters underlying the dominant position even if there is no first question since they seek essentially to restriction or elimination of competition clarify when a specific brick structure is to on a market distinct from that in which the be deemed indispensable for the marketing owner of the copyright exploits his right of studies on regional sales of medicines in a and holds a dominant position but is merely given country. More specifically, the preventing potential competitors from oper- national court seeks to ascertain whether ating on the same market as the dominant the following factors are material to such undertaking. assessment: (i) the level of participation of the representatives of the pharmaceutical companies in the development of the structure protected by copyright; (ii) the lengths (particularly, in terms of cost) to which the pharmaceutical companies should be required to go in order to acquire 31. Moreover, it has already been pointed studies carried out on the basis of a out that, with specific reference to that structure differing from the one protected aspect, IMS had criticised the Commission's by copyright. approach, arguing that it was 'entitled to refuse to grant a licence over its own copyright to competitors operating on the market concerned by the copyright itself'. 30 It is specifically on this aspect that, as has been seen, the President of the Court of First Instance dwelt when he held to be prima facie well founded (or at least not 33. Having thus clarified the scope of the manifestly unfounded) the arguments of questions, I will immediately turn to an IMS alleging that the Commission had examination of them, starting with the first
30 — Paragraph 182 of the Commission Decision. 31 — Paragraph 105 of the order of the President.
I - 5051
OPINION OF MR TIZZANO — CASE C-418/01
and then considering the second and third undesirable consequences for the market together. Once that examination has been economy inasmuch as it would deprive the concluded, it will finally be appropriate to owners of an intellectual property right of make a few brief observations on the the due recompense for their creative problems relating to the simultaneous endeavour and would act as a disincentive application of Article 82 EC by the national to investments in innovation and research. court and the Commission.
First question
Arguments of the parties 35. IMS goes on to observe that in a case such as that under examination the refusal to grant a licence would also not be capable of constituting an abuse of a dominant position under the essential facility doctrine 34. With reference to the first question IMS on which the Commission Decision is begins by stressing that the power of essentially based. According to that doc- exclusive enjoyment of an intellectual prop- trine the dominant undertaking must offer erty right and thus the owner's power to on an (upstream) market the goods or refuse to others a licence to use it constitu- services which are indispensable for com- tes an essential element of that right. For peting with it on a second (downstream) that reason, as has been elucidated in the market: in that situation, by unjustly deny- case-law, the mere refusal to grant a licence, ing access to its goods or services the even if it is by an undertaking having a dominant undertaking would be abusively dominant position, cannot of itself be restricting competition on the downstream determinative of abusive conduct within market. 33 Thus, the essential facility doc- the meaning of Article 82 EC. That provi- trine cannot require the dominant under- sion can be infringed only if the refusal to taking to share with other operators an grant the licence is accompanied by a intellectual property right solely in order to further element constituting abusive con- duct. 32 Any other interpretation of the provision whereby a refusal to grant a licence could be declared per se abusive 33 — According to IMS all the judgments of the Community Courts and the Commission decisions concerning the would moreover have very serious and refusal to grant a contract and essential facilities are to that effect. In that connection it makes specific reference to the judgments of the Court in Joined Cases 6/73 and 7/73 Commercial Solvents [1974] ECR 223; Case 311/84 Télémarketing [1985] ECR 3261; Case C-18/88 GB- Inno-BM [1991] ECR I-5941; Magill; Case C-7/97 32 — In that connection IMS cites Case 238/87 Volvo [1988] Bronner [1998] ECR I-7791; Case T-504/93 Ladbroke ECR 6211 and Case 53/87 Renault [1988] ECR 6039 and [1997] ECR II-923; and Commission Decision of 14 Joined Cases C-241/91 P and C-242/91 P RTE and ITP v January 1998 concerning a procedure under Article 86 of Commission [1995] ECR I-743, paragraph 49, hereinafter the EC Treaty (Case IV/34.801 FAG — Flughafen the 'Magill' judgment. Frankfurt Main AG (OJ 1998 L 72, p. 30)).
I - 5052
IMS HEALTH
allow the latter to compete with it more obligations of the Community under the effectively on the same market on which it WTO agreement on aspects of intellectual is exploiting its right. property rights relating to trade and the Bern Convention on the protection of literary and artistic works.
38. NDC's pleas and submissions are 36. IMS stresses, moreover, that in the plainly to the contrary. present case no reliance may be placed on the Magill judgment in order to maintain that the refusal to grant a licence constitutes an abuse of a dominant position. In that judgment the Court confirmed that a refusal to grant a licence may constitute 39. In particular that company maintains an abuse only in exceptional cases where (i) that the facts of the present case are it prevents the appearance of a new product analogous in a number of respects with not offered by the dominant undertaking the Magill case in which the Court held that which owns the intellectual property right the refusal by the owner of the copyright to and for which there is a potential demand; grant a licence constituted an abuse. As in (ii) it is unjustified; (iii) it has the effect of that case, reserving a derivative market to the domi- nant undertaking. In the present case the first and third conditions are not satisfied inasmuch as NDC is not seeking to introduce a new product on a derivative market but wishes to avail itself of the structure developed by IMS in order to — the intangible asset protected by copy- supply on the same market a product right is not the result of great creative almost identical to that developed by that effort and considerable investment (in company. the present case the structure is based to a large extent on the borders of the German postal codes and was brought into existence thanks to the decisive contribution of the pharmaceutical industry):
37. In the view of IMS, finally, to interpret Article 82 EC as meaning that the refusal of a dominant undertaking to grant a licence — the asset is made available to persons in itself constitutes an abuse would be an who are not in competition with the infringement (a) of the right of property owner of the copyright (in the present protected by the European Convention on case, for example, cartography ser- Human Rights; (b) of the international vices).
I - 5053
OPINION OF MR TIZZANO — CASE C-418/01
— the product offered by the undertaking 41. Finally, NDC observes that for refusal seeking the licence is in many respects to grant a licence to constitute an abuse it is better than that produced by the owner not necessary for there to be two separate of the copyright (in the present case markets (upstream and downstream). 35 As there is a wider spectrum of data, on- may be inferred from the Magill judgment, line access is offered and the significa- for the application of Article 82 EC it is tive value of the data is greater and sufficient that the dominant undertaking on they are presented in a more customer- a given market holds a monopoly on friendly manner. information necessary for competing with it. The fact that such information is not offered on the market by the dominant undertaking is immaterial.
— the monopoly situation in regard to the upstream activity (in this case the brick structure) would be extended to down- 42. For its part the Commission maintains stream activity (marketing of studies that for the refusal by a dominant under- on regional sales of medicines). taking to allow its competitors access to an essential facility to be deemed an abuse it is not necessary for that facility to be in a market different from that in which the competitors seek to operate. To that end it is sufficient for the infrastructure to be located in an upstream production stage and for it to constitute a clearly separable input for the production of given upstream 40. The solution proposed by it is also goods or services. supported, in NDC's view, by the fact that it does not intend merely to reproduce the data collected by IMS but wishes autono- mously to collect and process the data on regional sales in order then to transpose them into a product of its own. Moreover, NDC stresses that in the present case the 43. More specifically, according to the intangible asset protected by the copyright Commission, for a given product or service constitutes a sectoral standard which, on to be deemed to be infrastructure or an the basis of the assessments by the Commis- essential input, it must be distinguishable sion in its guidelines on the applicability of from the downstream goods or services and Article 81 of the EC Treaty to horizontal between it and the downstream product or cooperation agreements, 34 should be as accessible as possible.
35 — in that regard NDC emphasises in particular that at paragraph 47 of the Magill judgment the Court did not assess whether in the present case two markets could 34 — OJ 2001 C 3, p. 2. technically be distinguished.
I - 5054
IMS HEALTH
service 'added value' must be created. That would reserve to the undertaking the approach based on the distinction between market in the downstream goods or service. various stages of production rather than on In that regard, the Commission goes on to the existence of separate markets is con- stress that copyright is a property right like firmed by the Court's analysis in the Magill any other with which it has in common the and Bronner judgments and by the Court of power of the owner to have exclusive rights First Instance in the Ladbroke judgment. of disposition over the (tangible or intangi- ble) asset which forms the subject-matter thereof but also the obligations flowing from competition law.
44. The mere fact that input essential for the production of the downstream goods or service is not independently marketed by the dominant undertaking does not operate Appraisal to exclude the unjustified refusal of access to that input from constituting abusive conduct. In that case as well refusal of access imposes a significant restriction of competition in the market for the down- 46. The question under examination, as stream goods or service in breach of has been seen, raises an important and Article 82 EC. The restriction would be delicate problem of interpretation of Arti- still more serious if the essential input were cle 82 EC concerning the obligation on a not in fact marketed given that the under- dominant undertaking to grant (for valu- takings concerned in the production of the able consideration) to its competitors the downstream goods or service could not right to use an intangible asset protected by secure that input indirectly by having copyright where that is essential for operat- recourse to third parties who had acquired ing on the same market in which that it from the dominant undertaking. undertaking is exploiting its right and occupying a dominant position.
45. That reasoning, the Commission adds, (a) Relevant case-law holds good also where the essential input is constituted by an intangible asset protected by copyright. If in fact that intangible asset is distinguishable from the downstream goods or service for the production of which it were essential, the refusal to grant 47. For the purposes of examining that a licence by the dominant undertaking question I believe that it is first necessary to owning the copyright would go beyond recall the judgments of the Court concern- the essential function of that right because it ing the possibility that a refusal to enter into
I - 5055
OPINION OF MR TIZZANO — CASE C-418/01
contractual relations may be deemed to was contrary to Article 86 of the EC Treaty constitute an abuse of a dominant position (now Article 82 EC) for a dominant under- in which (or at least in some of which) it is taking on the telediffusion market to refuse possible to discern an application of the without objective justification to allow essential facility doctrine, to which the television space to independent telemarket- parties have on several occasions ing undertakings thereby reserving to an referred. 36 associated company operations in that sphere, with the risk that that entails of eliminating all competition on that market. In regard to those facts the Court specifi- cally affirmed the principle that 'an abuse within the meaning of Article 86 is com- 48. In that connection I shall begin by mitted where, without any objective neces- recalling the Commercial Solvents judg- sity, an undertaking holding a dominant ment in which those problems were dealt position on a particular market reserves to with by reference to an interruption of the itself an ancillary activity which might be supply of raw materials. Upholding the carried out by another undertaking as part Commission Decision impugned in that of its activities on a neighbouring but case, the Court clarified that 'an under- separate market, with the possibility of taking which has a dominant position in the eliminating all competition from such market in raw materials and which, with undertaking.' 39 the object of reserving such raw material for manufacturing its own derivatives, refuses to supply a customer, which is itself a manufacturer of these derivatives, and therefore risks eliminating all competition on the part of this customer, is abusing its dominant position within the meaning of Article 8 6'. 37 50. With specific reference to intellectual property rights, the Volvo case must be considered next. In that case the Court was essentially asked whether that motor man- ufacturer was abusing its dominant position 49. In the Telemarketing judgment the on the (presumptive) market for original Court subsequently had occasion to specify spare parts by not granting to third parties that that reasoning 'also applies to the case a licence for the manufacture of such spare of an undertaking holding a dominant parts. In reply to that question the Court position on the market in a service which stated that 'the right of the proprietor of a is indispensable for the activities of another protected design to prevent third parties undertaking on another market.' 38 In that from manufacturing and selling or import- case the Community judicature held that it ing, without its consent, products incorpor- ating the design constitutes the very subject- matter of his exclusive right. It follows that 36 — With reference to that doctrine and its application in the United States and in Europe see in particular Opinion of Advocate General Jacobs in the Bronner case, cited above, paragraphs 45 to 53. 39 — Ibid. The same principle has been reaffirmed in a partly 37 — Paragraph 25 of the judgment cited. different context in the GB-Inno-BM judgment, para- 38 — Paragraph 26 of the judgment cited. graph 8.
I - 5056
IMS HEALTH
an obligation imposed upon the proprietor casters had abused the dominant position of a protected design to grant to third held by them on the market for their parties, even in return for a reasonable television programme listings, by invoking royalty, a licence for the supply of products their copyright over such listings in order to incorporating the design would lead to the prevent third parties from publishing proprietor thereof being deprived of the complete weekly guides to the programmes substance of his exclusive right, and that a of the various broadcasters. refusal to grant such a licence cannot in itself constitute an abuse of a dominant position.' 40 However, the Court added that 'the exercise of an exclusive right by the proprietor of a registered design in respect of car body panels may be prohibited by Article 86 if it involves, on the part of an 52. In that connection the Court primarily undertaking holding a dominant position, emphasised that it followed from the certain abusive conduct such as the arbi- judgment in Volvo that, although a refusal trary refusal to supply spare parts to to grant a licence in respect of an intellec- independent repairers, the fixing of prices tual property right cannot in itself consti- for spare parts at an unfair level or a tute an abuse of a dominant position, decision no longer to produce spare parts 'exercise of an exclusive right by the for a particular model even though many proprietor may, in exceptional circum- cars of that model are still in circulation, stances, involve abusive conduct.' 42In that provided that such conduct is liable to case, in the Court's view, the circumstances affect trade between Member States.' 41 were such as to constitute abusive conduct on the part of the appellant broadcasters since:
— first, 'the appellants — who were, by force of circumstances, the only 51. Giving judgment on an appeal from sources of the basic information on two judgments of the Court of First programme scheduling which is the Instance in the well-known Magill case the indispensable raw material for compil- Court had the opportunity of returning to ing a weekly television guide — gave the question of a refusal to grant a licence viewers wishing to obtain information for the use of an intellectual property right. on the choice of programmes for the In the judgments appealed against the week ahead no choice but to buy the Court of First Instance had upheld a weekly guides for each station and decision in which the Commission had draw from each of them the informa- adjudged that certain television broad- tion they needed to make comparisons. The refusal to provide basic informa-
40 — Volvo judgment, paragraph 8. 41 — Paragraph 9 The Court ruled essentially to the same effect in the Renault judgment, cited above. 42 — Paragraph 50.
I - 5057
OPINION OF MR TIZZANO— CASE C-418/01
tion by relying on national copyright the existence of an autonomous market for provisions thus prevented the appear- nationwide home-delivery schemes, was ance of a new product, a comprehen- required, inter alia, to assess 'whether the sive weekly guide to television refusal by the owner of the only nationwide programmes, which the appellants did home-delivery scheme in the territory of a not offer and for which there was a Member State, which uses that scheme to potential consumer demand. Such re- distribute its own daily newspapers, to fusal constituted an abuse under allow the publisher of a rival daily news- heading (b) of the second paragraph paper access to it constitutes an abuse of a of Article 86 of the Treaty.' 43 dominant position within the meaning of Article 86 of the Treaty, on the ground that such refusal deprives that competitor of a means of distribution judged essential for the sale of its newspaper.' 46
— Secondly, 'there was no justification for such refusal either in the activity of television broadcasting or in that of publishing television magazines.' 44
— Thirdly, 'the appellants, by their con- duct, reserved to themselves the sec- 54. After recalling the Magill judgment, the ondary market of weekly television Court observed that 'even if that case-law guides by excluding all competition in on the exercise of an intellectual property that market... since they denied access right were applicable to the exercise of any to the basic information which is the property right whatever', it would still be raw material indispensable for the necessary in order to plead the existence of compilation of such a guide.' 45 an abuse within the meaning of Article 86 of the Treaty, not only for 'the refusal of the service comprised in home delivery to be likely to eliminate all competition in the daily newspaper market on the part of the person requesting the service and [for] such refusal to be incapable of being objectively 53. Finally, the Court had the opportunity justified, but also for the service in itself to of examining the problem of the refusal to be indispensable to carrying on that per- grant a licence in the well-known Bronner son's business, inasmuch as there [was] no judgment. In that case the Court, positing actual or potential substitute in existence for that home-delivery scheme.' 47
43 — Paragraphs 53 and 54. 44 — Paragraph 53. 46 — Paragraph 37. 45 — Paragraph 56. 47 — Paragraph 41.
I - 5058
IMS HEALTH
(b) Inferences the existence of a market in the nationwide home-delivery scheme for daily newspapers even where the undertaking holding a monopoly in such a (hypothetical) market did not independently sell the home-deliv- ery scheme.
55. It may be inferred from the foregoing brief examination of the case-law that, as IMS has highlighted, in all the cases in which it has acknowledged that the refusal 57. Thus, in applying the case-law cited on to supply or make available certain (tangi- the refusal to grant a licence I consider it to ble or intangible) goods or services might be sufficient that it is possible to identify a constitute an abuse of a dominant position, market in upstream inputs, even where the the Court has distinguished between a market is a 'potential' one only, in the sense market for such goods or services that operating within it is a monopoly (upstream) and a derivative market (down- undertaking which decides not to market stream) in which they are utilised as inputs independently the inputs in question (not- for the production of other goods or withstanding that there is an actual demand services. The infringements of Article 82 for them) but to assert exclusive rights over established or presumed in those cases in a downstream market by restricting or fact concerned vertically integrated under- eliminating all competition on that market. takings which (at least hypothetically) by refusing to grant a licence abused their dominant position on an upstream market in order to restrict or eliminate competition on a downstream market.
58. To take a classic example of the essential facility doctrine it is instructive to consider the case where access to a port is indispensable in order to be able to provide maritime transport services in a given geographical market. For the purposes of such a case it may be assumed that the 56. As has been rightly pointed out by owner of the port uses that infrastructure NDC and the Commission, however, in on an exclusive basis in order to secure a order to identify an (upstream) market for monopoly over the market for maritime inputs the Court has not deemed it neces- transport services refusing without any sary that the latter be autonomously marketed by the dominant undertaking. In Magill the Court in fact identified a market for television listings even where they were 48 — In identifying the relevant market the Court does not seem to have taken into consideration the fact that the owner of not marketed independently by the televi- the delivery scheme provided a series of services to an independent publisher including home delivery of one of its sion broadcasters but merely offered free of daily newspapers. In that case the home-delivery scheme charge to certain newspapers. Then, in the was not sold independently hut formed part of a 'package' including the printing and sale i n kiosks of the daily Bronner judgment the Court acknowledged newspaper i nquestion.
I - 5059
OPINION OF MR TIZZANO — CASE C-418/01
objective justification to provide the neces- actual demand for them on the part of sary port services to arm's-length under- undertakings seeking to operate on the takings which make a request in that market for which those inputs are essential. regard. I consider that in such a case the case-law on the refusal to grant a licence must apply irrespective of the fact that the port services are not offered on the market. That fact does not preclude the possibility of identifying a market in port services requested by the maritime transport under- takings given that there is an actual demand 60. If I now turn to examine in light of the for such services and there are no obstacles foregoing the case canvassed in the first of a technical nature to the marketing question it must be recognised that in the thereof. In terms of the case-law on the present case the case-law on the refusal to refusal to grant a licence it may therefore be grant a licence cannot not be applied owing held that, by denying without justification to the sole fact that the undertaking seeking access to the port infrastructure, the owner the licence to use the brick structure intends of that infrastructure would be abusing its to operate on the same market as the owner dominant (monopoly) position on the of the copyright. In view of the fact that market for port services inasmuch as by that question proceeds on the assumption its conduct it would be eliminating any that the brick structure for which the competition on the secondary market for licence was sought is essential to the maritime transport services. marketing of the studies on regional sales of medicines in a given country, it is not hard to identify an upstream market for access to the brick structure (monopolised by the owner of the copyright) and a secondary downstream market for the sale of the studies.
61. That said, I must none the less add that the judgments of the Court on the refusal to 59. Since it has therefore been established grant a licence over an intellectual property that in order to be able to identify a market right lead me to believe that, in order for an for upstream inputs it is not necessary for unjustified refusal to be deemed abusive, it them to be marketed independently by the is not sufficient that the intangible asset undertaking controlling them, it seems forming the subject-matter of the intellec- plain to me that such a market may by tual property right be essential for operat- definition be always identified where: (a) ing on a market and that therefore, by the inputs in question are essential (since virtue of that refusal, the owner of the they cannot be substituted or duplicated) to copyright may eliminate all competition on operating on a given market; (b) there is an the secondary market.
I - 5060
IMS HEALTH
62. Even where those circumstances a potential consumer demand'; and (b) by obtain, in weighing the balance between way of that refusal the appellants [had] the interest in protection of the intellectual 'reserved to themselves the secondary mar- property right and the economic freedom of ket of weekly television guides by excluding its owner, on the one hand, and the interest all competition in that market'. in protection of free competition, on the other, the balance may in my view come down in favour of the latter interest only if the refusal to grant the licence prevents the development of the secondary market to the detriment of consumers. More specifically, I consider that the refusal to grant a licence 64. In that case the Court thus found it an may be deemed abusive only if the request- abuse to refuse to grant a licence in view of ing undertaking does not wish to limit itself the fact that the undertaking seeking the essentially to duplicating the goods or grant of a licence wished to place on the services already offered on the secondary market a weekly television guide different market by the owner of the intellectual from those produced by the owners of the property right but intends to produce goods copyright (inasmuch as it would not list the or services of a different nature which, programmes of a single broadcaster but although in competition with those of the would provide a conspectus) in order to owner of the right, answer specific con- satisfy a specific consumer need. In that sumer requirements not satisfied by existing way, the emergence of a 'new' product was goods or services. being prevented which would have been in competition with products marketed by copyright owners in the general market for weekly television guides.
65. Yet it is perhaps possible also to construe the Volvo judgment in this way. In that case the Court stated that 'a refusal to grant ... a licence cannot in itself constitute an abuse of a dominant posi- tion'. 50 Even though in that case a regis- tered design in respect of car body panels 63. That was in my view clearly held in the could be regarded as an essential input for Magill judgment in which, as has been seen, operating on the (presumptive) market for the Court held an unjustified refusal to original spare parts, it may be considered grant a licence to be abusive, inasmuch as that the Court did not deem the refusal to (a) 'it prevented the appearance of a new product, a comprehensive weekly guide to television programmes, which the appel- 49 — Paragraph 56. lants did not offer and for which there was 50 — Paragraph 8.
I-5061
OPINION OF MR TIZZANO — CASE C-418/01
grant a licence abusive owing to the fact Second and third questions that the undertaking seeking the licence wished to do no more than duplicate the products of the owner of the registered design, and thus produce original Volvo spare parts. 67. As has been said, by its second and third questions the national court seeks essentially to ascertain when a specific brick structure protected by copyright must be deemed indispensable for the marketing of studies on regional sales of medicines in a given country. More specifically, the national court seeks to ascertain whether the following factors are material to such assessment: (i) the level of participation of the representatives of the pharmaceutical companies in the development of the structure protected by copyright; (ii) the lengths (particularly, in terms of cost) to which the pharmaceutical companies would have to go in order to acquire studies 66. In light of all the foregoing considera- carried out on the basis of a structure tions I therefore consider that the reply to differing from that protected by copyright. the first question should be that Article 82 EC must be interpreted as meaning that the refusal to grant a licence for the use of an intangible asset protected by copyright entails an abuse of a dominant position within the meaning of that provision where (a) there are no objective justifications for such refusal; (b) use of the intangible asset is essential for operating on a secondary Parties' arguments market with the consequence that by way of such refusal the owner of the right would ultimately eliminate all competition on that market. However, that is subject to the condition that the undertaking seeking the licence does not wish to limit itself essen- 68. With reference to the problems raised tially to duplicating the goods or services by the questions under examination, IMS already offered on the secondary market by observes in general terms that client pref- the owner of the intellectual property right erences cannot justify classification of the but intends to produce goods or services of 1860 brick structure as an essential facility. a different nature which, although in In order to assess whether a brick structure competition with those of the owner of is essential to the marketing of the studies the right, answer specific consumer require- on regional sales of medicines, reference ments not satisfied by existing goods or may not be made to the subjective pre- services. paredness of customers to accept studies
I - 5062
IMS HEALTH
carried out on the basis of another struc- structure constitutes an essential facility, ture. In that connection the decisive factor given that in certain circumstances they can is whether it is objectively possible for a mean that access to an infrastructure is competitor of comparable dimensions to essential where it normally would not be. develop an alternative structure.
72. NDC goes on to emphasise that, in line 69. In regard to the role played by the with the Bronner judgment, access to a pharmaceutical companies in the develop- predetermined infrastructure may be ment of the brick structure, IMS observes deemed essential where the creation of an that a contribution by customers to the alternative infrastructure would not be creation of products or services more and economically viable. In the present case more in keeping with their requirements is the costs of adjustment which would have entirely normal. In that context the imposi- to be borne by the pharmaceutical compa- tion of a requirement to grant a licence has nies in order go over to another brick negative consequences inasmuch as it structure would be so great that the would incite the undertakings to forgo any introduction of a competing structure not contact with customers in regard to the only would not be profitable but would development of their products. indeed be economically unviable.
73. For its part the Commission points out 70. As to the costs of adjustment to be that its decision indicates numerous matters borne by customers in order to be able to in support of the contention that the IMS use studies carried out on the basis of other 1860 brick structure is indispensable for the structures, IMS observes finally that the fact marketing of studies on regional sales of that the customers must incur expenditure medicines in Germany. The matters men- in order to opt for a different product is tioned by the national court are thus only entirely normal and cannot be relevant in some of those which must be taken into establishing whether a refusal to grant a consideration for the purposes of that licence entails an abuse of a dominant assessment. position.
74. That stated, the Commission stresses 71. Conversely, NDC observes that indus- that the major involvement of customers in try practices or customer expectations are the development of the IMS brick structure relevant in establishing whether an infra- has contributed to creating a relationship of
I - 5063
OPINION OF MR TIZZANO— CASE C-418/01
dependency by the pharmaceutical compa- Assessment nies on that structure. In its view, that degree of regular and intense collaboration by customers aimed at the creation of a common structure for the provision of a series of compatible services displays the characteristics of a process leading to the establishment of a de facto standard. 77. For an analysis of the question under examination, it is appropriate to start with the Bronner judgment in which the Court provided certain useful indications in order to establish when a (tangible or intangible) asset or a service may be deemed to be essential for operating on a given market. 75. The Commission goes on to observe that in order to establish whether an infrastructure is essential, it must be assessed whether a competitor of analogous dimensions could create a valid alternative. For the purposes of that assessment, it would however be useful for there to be an attentive examination of the relevant fac- tors on the demand side and in particular of the adjustment efforts to be carried out by 78. In that case the Court specifically ruled customers in order to go over to another out that the only system of home delivery infrastructure. An analysis of the situation existing nationwide in a Member State was from the point of view of both supply and essential for the sale of daily newspapers, demand would in particular be opportune emphasising on the one hand that 'it is in order to establish whether the creation of undisputed that other methods of distribut- an alternative infrastructure is economically ing daily newspapers, such as by post and viable. through sale in shops and at kiosks, even though they may be less advantageous for the distribution of certain newspapers, exist and are used by the publishers of those daily newspapers.' Nor, moreover, were there 'any technical, legal or even economic obstacles capable of making it impossible, or even unreasonably difficult, for any other publisher of daily newspapers to 76. Referring to the assessments carried establish, alone or in cooperation with out in its decision, the Commission high- other publishers, its own nationwide lights the obstacles which in the present home-delivery scheme and use it to dis- case discourage the pharmaceutical compa- tribute its own daily newspapers.' 51 nies from moving to a brick structure incompatible with that of IMS and the extraordinary efforts, not only of a finan- cial nature, which that would entail. 51 — Paragraphs 43 to 44.
I - 5064
IMS HEALTH
79. The Court further ruled that 'in order the Court held, that their creation is not to demonstrate that the creation of such a economically viable for production on a system is not a realistic potential alternative scale comparable to that of the owner of and that access to the existing system is existing inputs. therefore indispensable, it is not enough to argue that it is not economically viable by reason of the small circulation of the daily newspaper or newspapers to be distributed. For such access to be capable of being regarded as indispensable, it would be necessary at the very least to establish ... 81. In the case under examination, as has that it is not economically viable to create a been stated, it is necessary to establish the second home-delivery scheme for the dis- relevance for the purposes of that assess- tribution of daily newspapers with a ment of: (i) the level of participation of the circulation comparable to that of the daily pharmaceutical undertakings in the devel- newspapers distributed by the existing opment of the structure protected by copy- scheme'. 52 right; (ii) the effort (particularly in terms of cost) to be made by the pharmaceutical undertakings in order to be able to acquire studies based on a structure other than the one protected by copyright.
82. In my view those aspects must be examined jointly inasmuch as they both manifest themselves ultimately as financial 80. It is therefore clear from that judgment obstacles to the creation of an alternative that, in order to establish whether an 'input' structure. is essential for operating on a given market, it must be assessed whether (a) there are substitute inputs, which may be used to operate (more or less effectively) on the market in question; (b) there are obstacles of a technical, legislative or financial nature which may make it impossible or unrea- 83. In fact, according to the submissions of sonably difficult for any undertaking seek- NDC and the Commission, the intense ing to operate on that market to create involvement of the pharmaceutical under- other inputs possibly in conjunction with takings in the development of the IMS other operators. For there to be obstacles of structure, although not an absolute techni- a financial nature to the creation of alter- cal or legal impediment to a move to an native inputs, it must at least be the case, alternative structure, is one of the causes of the dependency of the pharmaceutical companies on the existing structure. But if 52 — Paragraphs 45 to 46. it is so, the involvement of the pharmaceu-
I - 5065
OPINION OF MR TIZZANO — CASE C-418/01
tical industries in the development of the such an alternative structure possibly in IMS structure simply explains why those conjunction with other operators. industries have to make exceptional efforts in order to be able to go over to acquiring studies carried out on the basis of a different structure.
86. In light of the foregoing I therefore consider that the reply to the second and third questions should be that the level of participation of the pharmaceutical under- takings in the development of the structure 84. However, it is clear that if the pharma- protected by copyright and the effort to be ceutical industries had to make exceptional made by the pharmaceutical undertakings (organisational and financial) efforts in in order to be able to acquire studies based order to go over to another structure, that on a structure other than the one protected would render the creation of such a by copyright are matters to be taken into structure by a competitor of IMS more account in establishing whether the latter onerous or, depending on one's viewpoint, structure is essential for the marketing of less profitable. To persuade potential cus- studies on regional sales of medicines. tomers to acquire studies carried out on the basis of the alternative structure the com- petitor of IMS would have to offer them particularly favourable terms with the risk that the investments made would not be amortised.
Simultaneous application of Article 82 EC by the national courts and the Commission
85. It must therefore be deduced that the level of participation of the pharmaceutical undertakings in the development of the structure protected by copyright and the 87. As indicated, before concluding I effort to be made by the pharmaceutical would like to devote certain summary undertakings in order to be able to acquire considerations to the problems arising in studies based on a structure other than the the present case with reference to the one protected by copyright are elements to application in this context of Article 82 be taken into account in establishing EC by the national courts and the Commis- whether or not there are obstacles of a sion. Those problems arise inasmuch as the technical, legislative or financial nature judgment to be delivered by the Court in which may make it impossible or extra- the present case, although indicating the ordinary difficult for any other undertaking manner in which Article 82 EC is to be seeking to operate on that market to create interpreted in regard to the questions
I - 5066
IMS HEALTH
formulated by the national court, will inasmuch as the interim nature of a decision presumably leave to the latter a certain certainly does not detract from its binding margin of appreciation in order to establish force or from the abovementioned duty of whether the refusal by IMS to grant a cooperation. As the Court has, moreover, licence constitutes an abuse of a dominant clarified, the prohibition on adopting deci- position. In theory the national court could sions in breach of Commission decisions give a ruling in conflict with the Commis- applies even where the operation of such sion Decision which established that such decisions is suspended on an interim basis refusal was prima facie contrary to Arti- by an order of the President of the Court of cle 82 EC. First Instance. 55
89. Plainly, if the national court, within the context of the margin of appreciation which will presumably be left to it by the Court, were to have any doubts on the validity of 88. In such a situation it seems to me the Commission decision, it could in that opportune to point out that the Court has connection raise a new question for a already had occasion to clarify that 'when preliminary ruling. 5 6Where it deems it national courts rule on agreements or opportune, the national court may also stay practices which are already the subject of its proceedings pending final judgment by a Commission decision [under Article 81 or the Court of First Instance on the Commis- Article 82 EC] they cannot take decisions sion's interim decision or await its definitive running counter to that of the Commis- decision, 57 possibly having first consulted sion.'53That prohibition, which is founded the Commission. As emphasised by the on the duty of cooperation enshrined in Court, where proceedings are stayed, the Article 10 EC and the binding force of national court must examine whether it is decisions adopted by the Commission necessary to order interim measures in pursuant to Articles 81 or 82 EC, 54 must order to safeguard the interests of the in my view also apply whenever that parties pending final judgment.58 institution has ruled on an interim basis,
55 — Paragraph 53. 53 — Case C-344/98 Masierfoods [2000] KCR I-11369, para- 56 — Paragraph 57. graph 52. 57 — Paragraph 57. 54 — Paragraphs 49 and 50. 58 — Paragraph 58.
I - 5067
OPINION OF MR TIZZANO — CASE C-418/01
Conclusion
90. In light of the foregoing considerations I therefore propose that the Court should reply to the Landgericht in the following terms:
(1) Article 82 EC should be interpreted as meaning that the refusal to grant a licence for the use of an intangible asset protected by copyright entails an abuse of a dominant position within the meaning of that provision where (a) there are no objective justifications for such refusal; (b) use of the intangible asset is essential for operating on a secondary market with the consequence that by way of such refusal the owner of the right would ultimately eliminate all competition on that market. However, that is subject to the condition that the undertaking seeking the licence does not wish to limit itself essentially to duplicating the goods or services already offered on the secondary market by the owner of the intellectual property right but intends to produce goods or services of a different nature which, although in competition with those of the owner of the right, answer specific consumer requirements not satisfied by existing goods or services.
(2) The level of participation of the pharmaceutical undertakings in the development of the structure protected by copyright and the effort to be made by the pharmaceutical undertakings in order to be able to acquire studies based on a structure other than that protected by copyright are matters to be taken into account in establishing whether the latter structure is essential for the marketing of studies on regional sales of medicines.
I - 5068